NCM
CCXI

Nantahala Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Nantahala Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300,000
Closed -$11.9M – 112
2019
Q4 		$11.9M Hold
300,000
– – 0.37% 47
2019
Q3 		$2.03M Buy
+300,000
New +$2.25M 0.08% 84

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Nantahala Capital Management's CCXI Position: Q3 2020 in Review

Nantahala Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 4,859 shares — an estimated $280K sold.

Nantahala Capital Management first reported a position in CCXI in Q2 2016 and held it in 12 quarters. The position peaked at $8.17M in Q1 2018. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Nantahala Capital Management reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • Nantahala Capital Management sold 4,859 ChemoCentryx, Inc. shares in Q3 2020, an estimated $280K.
  • Nantahala Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2016 and held it in 12 quarters.
  • Nantahala Capital Management's ChemoCentryx, Inc. position peaked at $8.17M in Q1 2018.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Nantahala Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.